Ascend Minocycline 115mg Recall
Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg because some bottles failed to meet dissolution specifications …
Ascend Laboratories, LLC
Every recall we are tracking for Ascend Laboratories, LLC, newest first, sourced from the FDA. If you are wondering whether your Ascend Laboratories, LLC product is recalled in 2026, check the list below for your model, lot, or VIN. Each entry explains the hazard and the free repair, replacement, or refund. Get a free email alert the moment a new Ascend Laboratories, LLC recall posts.
1 recall · updated Jun 1, 2026
Fresenius Kabi is recalling Naropin (ropivacaine hydrochloride injection) 0.5%, 20 mL single-dose vials because hair was found in some products. Use of …
Fresenius Kabi USA, LLC
Rohto Cooling Eye Drops Max Strength (0.4 FL OZ / 13 mL bottles) has been recalled because the manufacturer cannot confirm the product is sterile. Using …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Rohto Cooling Eye Drops Cool Relief has been recalled because the manufacturer cannot guarantee the product is sterile. Use of non-sterile eye drops can lead to …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Major Pharmaceuticals is recalling Levothyroxine Sodium 88 mcg tablets because they are subpotent, meaning they contain less active ingredient than labeled. …
Major Pharmaceuticals
Major Pharmaceuticals' Levothyroxine Sodium Tablets, USP 75 mcg, have been found to be subpotent, meaning they contain less active ingredient than stated. …
Major Pharmaceuticals
Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets 150 mcg because some batches contain less active ingredient than labeled, which means they may …
Major Pharmaceuticals
Be the first to know if Ascend Laboratories, LLC issues a recall.
Free forever. Unsubscribe anytime. We never sell your data.